Beck Bode’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Beck Bode's VRTX Position: Q1 2024 in Review
Beck Bode sold out of Vertex Pharmaceuticals (VRTX) in Q1 2024, closing a stake of 28,875 shares — an estimated $11.7M sold.
Beck Bode first reported a position in VRTX in Q3 2020 and held it in 11 quarters. The position peaked at $11.7M in Q4 2023. 1,497 funds tracked by Wall St. Rank hold VRTX as of Q1 2024.
- Beck Bode reported no remaining Vertex Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
- Beck Bode sold 28,875 Vertex Pharmaceuticals shares in Q1 2024, an estimated $11.7M.
- Beck Bode first reported a position in Vertex Pharmaceuticals in Q3 2020 and held it in 11 quarters.
- Beck Bode's Vertex Pharmaceuticals position peaked at $11.7M in Q4 2023.
- 1,497 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2024.
Based on Beck Bode's 13F filing for Q1 2024, filed 22 May 2024.